Toggle Main Menu Toggle Search

Open Access padlockePrints

LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages

Lookup NU author(s): Dr Julien Peltier, Professor Matthias TrostORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2018 EMBO. Mutations in the leucine-rich repeat kinase 2 (LRRK2) are associated with Parkinson's disease, chronic inflammation and mycobacterial infections. Although there is evidence supporting the idea that LRRK2 has an immune function, the cellular function of this kinase is still largely unknown. By using genetic, pharmacological and proteomics approaches, we show that LRRK2 kinase activity negatively regulates phagosome maturation via the recruitment of the Class III phosphatidylinositol-3 kinase complex and Rubicon to the phagosome in macrophages. Moreover, inhibition of LRRK2 kinase activity in mouse and human macrophages enhanced Mycobacterium tuberculosis phagosome maturation and mycobacterial control independently of autophagy. In vivo, LRRK2 deficiency in mice resulted in a significant decrease in M. tuberculosis burdens early during the infection. Collectively, our findings provide a molecular mechanism explaining genetic evidence linking LRRK2 to mycobacterial diseases and establish an LRRK2-dependent cellular pathway that controls M. tuberculosis replication by regulating phagosome maturation.


Publication metadata

Author(s): Hartlova A, Herbst S, Peltier J, Rodgers A, Bilkei-Gorzo O, Fearns A, Dill BD, Lee H, Flynn R, Cowley SA, Davies P, Lewis PA, Ganley IG, Martinez J, Alessi DR, Reith AD, Trost M, Gutierrez MG

Publication type: Article

Publication status: Published

Journal: EMBO Journal

Year: 2018

Volume: 37

Issue: 11

Print publication date: 01/06/2018

Online publication date: 22/05/2018

Acceptance date: 24/04/2018

Date deposited: 12/06/2018

ISSN (print): 0261-4189

ISSN (electronic): 1460-2075

Publisher: Wiley - VCH Verlag

URL: https://doi.org/10.15252/embj.201798694

DOI: 10.15252/embj.201798694


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
F1002
FC001092
MC_UP_1202/11
MC_UU_12016/5
MR/N026004/1
MR/L010933/1
WTISSF121302

Share